AMYLOID SOLUTION

Erasing Alzheimer's Disease

Seongnam, South Korea · $61.2M raised

Headquarters
Seongnam
Employees
11–50
Business Model
B2B
Total Funding
$61.2M
Last Round
$33.6M Series CApr 2020
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Amyloid Solution Inc. is a South Korean biotechnology company developing innovative disease-modifying treatments for Alzheimer's disease. The company targets patients at various stages of the disease with diverse pathological alterations, pursuing a comprehensive approach to overcome Alzheimer's through next-generation therapeutics. Amyloid Solution collaborates with world-class experts and has an FDA-tracked Phase 1 candidate (AS-S603) in clinical development.

Summary

AMYLOID SOLUTION is a Biotech company based in Seongnam, South Korea. It has raised $61.2M in total across 3 rounds, most recently a $33.6M Series C round in Apr 2020. Investors include T S Investment and WONIK Investment Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2020
$14.8M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AMYLOID SOLUTION on Indexed.vc
<a href="https://indexed.vc/companies/amyloid-solution"><img src="https://indexed.vc/api/badge/company/amyloid-solution" alt="AMYLOID SOLUTION on Indexed.vc" width="260" height="76" /></a>